By Apoorva Mandavilli Knowing the amount of virus carried in the body could help doctors predict the course of a patient’s illness. A patient in the emergency room of a hospital in Los Angeles awaited the results of a coronavirus test this month. Credit…Jae C. Hong/Associated Press As Covid-19 patients flood into hospitals nationwide, doctors are facing an impossible question. Which patients in...
by Tori Marsh December 21, 2020, 10:10AM Amidst the worst of the pandemic, drug prices continue to rise. Each year, in January and July, manufacturers raise the list price of their medications, and we predict that this year will be no different. Every day this January, the GoodRx Research Team will be tracking price increases...
by Public Library of Science SEM of a mosquito (Anopheles stephensi) clearly showing the wing, proboscis, antennae, abdomen and legs. Anopheles stephensi is one of the major vectors of urban malaria in India and some parts of Asia. Malaria is caused by parasites (Plasmodium species) which enter the blood when infected mosquitoes feed. Anopheles stephensi is commonly used in research as...
MASSACHUSETTS GENERAL HOSPITAL BOSTON – Reports of possible allergic reactions to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, both recently approved for emergency use by the U.S. Food and Drug Administration (FDA), have raised public concern. A team of experts led by allergists at Massachusetts General Hospital (MGH) has now examined all relevant information...
By Rich Haridy December 30, 2020 A VR system has been shown to enhance the pain-relieving effect of a therapy called spinal cord simulation A compelling new study, published in the journal Pain, has found integrating an immersive virtual reality system into a chronic pain treatment can significantly enhance a patient’s pain-relief outcome. The research suggests...
by Brigham and Women’s Hospital Credit: Pixabay/CC0 Public Domain A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc. Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine...
by National Institutes of Health In an in-depth study, NIH researchers consistently found blood vessel damage in the brains of COVID-19 patients but no signs of SARS-CoV-2 infections. Here is a high-resolution scan of a patient’s brain stem. Arrows point to light and dark spots that are indicative of blood vessel damage observed in the study....
by John Hewitt , Medical Xpress Credit: Wikipedia Individuals with different genetic variants in their immune system components often have very different immune responses to Sars-CoV-2. They also will have different responses to vaccines. By the same token, newly emerged variants in Sars-Cov-2 can elicit different immune responses in identical immune systems. In the larger...
by Jonathan Gardner@ByJonGardner Jud Broadhurst was 14 years old when he began to notice the symptoms. Playing competitive soccer, Broadhurst would fall, seemingly “for no reason,” he said. But there was one, lurking in his genes. Broadhurst had a form of spinal muscular atrophy, a rare neuromuscular condition that was causing his muscles to weaken...
By Jonathan Gardner, Ned Pagliarulo, Ben Fidler Approvals for vaccines developed by Pfizer and Moderna have kicked off immunization campaigns in the U.S. and Europe. Others could come soon as late-stage trials wrap up.By Jonathan Gardner, Ned Pagliarulo, Ben Fidler Scientists, drugmakers and governments have moved with unprecedented haste to develop a vaccine against the new coronavirus. The...
